Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy

Transfusion. 2024 Apr;64(4):762-765. doi: 10.1111/trf.17793.

Authors

Nilu Perera^{1

2}, Shoma Baidya³, Nicholas Weber¹, Kari Mudie¹, Jason Butler¹, Cameron Curley^{1

2}, Andrea Henden^{1

2

4}, Stewart Hunt³, Elango Subramoniapillai¹, Siok-Keen Tey^{1

4}, Glen A Kennedy¹, Ashleigh P Scott^{1

2}

Affiliations

¹ Department of Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Herston, Australia.
² Faculty of Medicine, The University of Queensland, St Lucia, Australia.
³ Australian Red Cross Lifeblood, Melbourne, Australia.
⁴ Translational Cancer Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Australia.

PMID: 38593296
DOI: 10.1111/trf.17793

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD19
Cytopenia*
Granulocytes
Humans
Immunotherapy, Adoptive
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen
Antigens, CD19